Can Imipramine help with Generalized Anxiety Disorder?

For individuals facing treatment-resistant Generalized Anxiety Disorder (GAD), exploring alternative medication options becomes crucial in the quest for relief. When traditional treatments such as selective serotonin reuptake inhibitors (SSRIs) or benzodiazepines prove ineffective, healthcare professionals should consider other classes of medications.

Watch the following YouTube video on the role of Impiramine in Generalized Anxiety Disorder treatment:

DETAILED LECTURE SERIES FOR ACADEMY MEMBERS:

Generalized Anxiety Disorder (GAD) is a common psychiatric disorder with chronic waxing and waning course for some. Psychiatry Education Forum Academy will summarize the pharmacological treatment of GAD in the following three sections:

(1) GAD: Initial Serotonergic Medication of Choice?

ACADEMY

(2) Treatment Resistant GAD: Augmentation Strategies

ACADEMY

(3) Treatment Resistant GAD: Switch Options

ACADEMY

JOIN EMAIL NEWSLETTER (FREE):

INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?

JOIN ACADEMY MEMBERSHIP:

This is a closed membership for medical professionals only.

  • 400+ Clinically Relevant Chapters: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Clinical Case Discussion: Dr. Singh (Psychiatry) and Dr. Kaur (Family Medicine) discuss clinical cases to integrate the clinical cases from Psychiatry and Medicine.
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
GENERAL
$ 150/YR
  •  
STUDENTS
$ 99/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

© 2024 All Rights Reserved.

Related Articles